- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2022 MJH Life Sciences™ and Cancer Network. All rights reserved.
ONCOLOGY Staff | Authors
Recap: Mobocertinib for Pretreated Patients With EGFR Exon 20 Insertion–Positive Metastatic NSCLC
May 26, 2022
Expert oncologists review safety/efficacy data behind mobocertinib, a small molecule tyrosine kinase inhibitor, in patients with EGFR exon 20 insertion–positive metastatic non–small cell lung cancer.
Recap: Earlier Detection May Be Key to Treatment Advances in Chronic GVHD
May 25, 2022
An expert in hematology/oncology, Dr Yi-Bin Chen, provides insight on chronic GvHD, with a focus on early detection of disease and therapeutic options for the management of steroid-refractory chronic GvHD.
Recap: Advances in Systemic Therapy of Differentiated Thyroid Cancer Across Lines of Therapy
May 24, 2022
Lori Wirth, MD, provides an overview of differentiated thyroid cancer including treatment options that are currently available, as well as sharing insights on emerging therapies.
Recap: Updates of Androgen Deprivation Therapy in Prostate Cancer
May 23, 2022
Expert panelists center discussion around two patient cases to review use of newer anti-androgen deprivation therapy in the management of prostate cancer.
Recap: A Review of Multiple Myeloma Trials That Impact the Standard of Care
May 20, 2022
A panel of experts provides a discussion on treatments for newly diagnosed transplant-eligible and transplant-ineligible relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.
Recap: Treatment Advances in Chronic GVHD
May 15, 2022
A panel of experts in stem cell transplant and cellular immunotherapy builds a lively discussion on current and emerging treatment options for the management of acute and chronic graft versus host disease.
2022 Genitourinary Cancers Symposium 2-Minute Drill: Experts Review Most Impactful Data
April 20, 2022
Thought leaders Daniel P. Petrylak, MD; Benjamin H. Lowentritt, MD; Alan H. Bryce, MD; and Tanya Dorff, MD, joined CancerNetwork® following the 2022 Genitourinary Cancers Symposium to discuss highlights of the meeting in a game show–style production.
Viability and Future of Maintenance Therapy in Solid Tumors
April 06, 2022
Shilpa Gupta, MD, and Jason R. Brown, MD, PhD, discuss a recently published paper by Grivas et al. (2019) on the use of checkpoint inhibitors for maintenance therapy to prolong the benefits of frontline therapy while minimizing toxicity in solid tumors.